SCHEMBL1707475

SCHEMBL1707475

CCCCCCCCC(O)C(O)CCCCCCCCO

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.65
ALDH1A1 P00352 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
HSD17B10 Q99714 1/20 0.65
TSHR P16473 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.60
CYP2D6 P10635 2/20 0.59
SPHK1 Q9NYA1 2/20 0.59
GMNN O75496 1/20 0.59
POLB P06746 1/20 0.59
THPO P40225 1/20 0.59
MTOR P42345 1/20 0.59
BLM P54132 1/20 0.59
KDM4E B2RXH2 1/20 0.59
TP53 P04637 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
MAPT P10636 1/20 0.59
CETP P11597 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3895284 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL15508603 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL10881142 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL21552422 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL15505935 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL23081061 1.00 LMNA (0.65) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL16078673 0.95 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL16078697 0.95 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL16078658 0.95 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL16078622 0.95 LMNA (0.59) LMNAALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116836531-A Polyol-containing polyhydroxyalkanoate composition with high fluidity, molded body and preparation method thereof 北京蓝晶微生物科技有限公司 2023-10-03 CN claimed
US-7635742-B2 Crosslinking polyurethanes RHODIA CHIMIE (FR) 2009-12-22 US claimed
EP-1382626-A1 Modified isocyanates Rhodia Chimie (FR) 2004-01-21 EP claimed
EP-1129120-B1 MODIFIED POLYISOCYANATES RHODIA CHIMIE SA (FR) 2003-12-10 EP claimed
US-20260062720-A1 Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof AGAIN BIO APS (DK) 2026-03-05 US disclosed
US-20240309405-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF OXFORD FINANCE LLC 2024-09-19 US disclosed
CN-116836531-A Polyol-containing polyhydroxyalkanoate composition with high fluidity, molded body and preparation method thereof 北京蓝晶微生物科技有限公司 2023-10-03 CN disclosed
US-20210189439-A1 Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof GENOMATICA, INC. (US) 2021-06-24 US disclosed
EP-3810778-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF Genomatica, Inc. (US) 2021-04-28 EP disclosed
WO-2019217226-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF REG Life Sciences, LLC (US) 2019-11-14 WO disclosed
CN-102803448-A Biolubricant esters of alcohols from unsaturated fatty acids CHEVRON USA INC 2012-11-28 CN disclosed
US-8304574-B2 Biolubricant esters from the alcohols of unsaturated fatty acids CHEVRON U.S.A. INC. (US) 2012-11-06 US disclosed
CN-1058609-A The method of preparing washing and dry-clean active granules HENKEL KGAA (DE) 1992-02-12 CN disclosed
EP-0116905-B1 USE OF ALCOHOLS DERIVATIVES AS VISCOSITY REGULATORS FOR HIGHLY VISCOUS CONCENTRATES OF TECHNICAL SURFACTANTS Henkel Kommanditgesellschaft auf Aktien (DE) 1988-01-20 EP disclosed
US-4495092-A REDUCING THE VISCOSITY OF A-SULFOFATTY ACID ESTERCONCENTRATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1985-01-22 US disclosed
EP-0116905-A2 Use of alcohols derivatives as viscosity regulators for highly viscous concentrates of technical surfactants Henkel Kommanditgesellschaft auf Aktien (DE) 1984-08-29 EP disclosed
EP-0024375-B1 YARN TREATING COMPOSITION FOR HIGH-SPEED FRICTION DRAW-FALSE TWIST TEXTURING AND A FILAMENTARY YARN TREATED WITH THE SAME TEIJIN LIMITED (JP) 1983-02-23 EP disclosed
US-4351738-A ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER TEIJIN LIMITED (JP) 1982-09-28 US disclosed
EP-0024375-A1 Yarn treating composition for high-speed friction draw-false twist texturing and a filamentary yarn treated with the same TEIJIN LIMITED (JP) 1981-03-04 EP disclosed
US-4092337-A FLAMEPROOFING AGENTS FOR SYNTHETIC FIBERS CIBA-GEIGY CORPORATION (US) 1978-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062720-A1 Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof FASN, FFAR1, FFAR3 LMNA 3981/4885ALDH1A1 398/4885MEN1 4053/4885
US-20240309405-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF DGAT2, DGAT1, FASN LMNA 4765/4885ALDH1A1 1172/4885MEN1 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.